The impact of caudate lobe involvement after hepatic resection for colorectal metastases

European Journal of Surgical Oncology

Volumn 35, Issue 5, 2009, Pages 510-514

  Khan, A Z ^a   Wong, V K ^a   Malik, H Z ^a   Stiff, G Morris ^a   Prasad, K R ^a   Lodge, J P A ^a   Toogood, G J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Caudate lobe; Colorectal metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FEMALE; HOSPITAL; HUMAN; LENGTH OF STAY; LIVER CAUDATE LOBE; LIVER METASTASIS; LIVER RESECTION; LIVER STRUCTURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL TIME; TERTIARY HEALTH CARE;

BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 63049106994     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.008     Document Type: Article

References (42)

1. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-827
2. Fernandez F.G., Drebin J.A., Linehan D.C., Dehdashti F., Siegel B.A., and Strasberg S.M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-450
3. Nordlinger B., Van Cutsem E., Rougier P., et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43 14 (2007) 2037-2045
4. Aloia T.A., Vauthey J.N., Loyer E.M., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 (2006) 460-467
5. Abdalla E.K., Vauthey J.N., and Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am 11 (2002) 835-848
6. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 5 (2005) 715-724
7. Rappeport E.D., Loft A., Berthelsen A.K., et al. Contrast-enhanced FDG-PET/CT vs. SPIO-Enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48 4 (2007) 369-378
8. Bipat S., van Leeuwen M.S., Ijzermans J.N., et al. Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 65 1 (2007) 5-14
9. Gollub M.J., Schwartz L.H., and Akhurst T. Update on colorectal cancer imaging. Radiol Clin North Am 45 1 (2007) 85-118
10. Chapman W.C., Hoff P.M., and Strasberg S.M. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej, et al. Ann Surg Oncol 13 10 (2006) 1269-1270
11. Hamady Z.Z., Cameron I.C., Waytt J., Prasad R.K., Toogood G.J., and Lodge J.P.A. Resection margin in patients undergoing hepatectomy for colorectal metastases: a critical appraisal of the 1 cm rule. Eur J Surg Oncol 32 5 (2006) 557-563
12. Fukada T., Kimura F., Takayasiki T., et al. Anterior transhepatic approach for hepatocellular carcinoma located in deep positions of segment VIII. Hepatogastroenterology 54 74 (2007) 536-538
13. Strasberg S.M. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12 (2005) 351-355
14. Strasberg S.M. International Hepato-Pancreato-Biliary Association Terminology Committee Survey: the Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2 (2000) 333-339
15. Kumon M. Anatomy of the caudate lobe with special reference to portal vein and bile duct. Acta Hepatol Jpn 26 (1985) 1193-1199
16. Shimada M., Matsumata T., Maeda T., Yanaga K., Taketomi A., and Sugimachi K. Characteristics of hepatocellular carcinoma originating in the caudate lobe. Hepatology 19 (1994) 911-915
17. Seror O., Haddar D., N'Kontchou G., et al. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe. J Vasc Interv Radiol 16 7 (2005 Jul) 981-990
18. Tono T., Ohzato H., Fukunaga M., Hasuike Y., Nakagawa H., Monden T., et al. Surgical treatment of hepatic lobe metastases originating from colorectal primaries. Int Surg 85 (2000) 237-242
19. Nagasue N., Kohno H., Yamanoi A., et al. Resection of the caudate lobe of the liver for primary and recurrent hepatocellular carcinomas. J Am Coll Surg 184 (1997) 1-8
20. Lodge J.P., Ammori B.J., Prasad K.R., and Bellamy M.C. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg 231 4 (2000) 471-479
21. Morise Z., Yamafuji K., Asami A., et al. Hepatectomy following transarterial chemotherapy for a metastasis in the caudate lobe. HepatoGastroenterology 51 (2004) 583-585
22. Yamamoto H., Nagino M., Kamiya J., Hayakawa N., and Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery 137 (2005) 26-32
23. Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
24. Hawkins W.G., DeMatteo R.P., Cohen M.S., et al. Caudate hepatectomy for cancer: a single institution experience with 150 patients. J Am Coll Surg 200 3 (2005) 345-352
25. Malik H.Z., Prasad K.R., Halazun K.J., et al. Pre-operative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246 5 (2007) 806-814
26. Abdalla E.K., Ribero D., Pawlik T.M., et al. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11 1 (2007) 66-72
27. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 100 (1986) 2782-2784
28. Nordlinger B., Quilichini M.A., Parc R., Hannoun L., Delva E., and Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205 (1987) 256-263
29. Tanaka K., Shimada H., Yamada M., et al. Clinical features and surgical outcome of hepatic caudate lobe metastases from colorectal cancer. Anticancer Res 26 (2006) 1447-1454
30. Tanaka K., Shimada H., Matsuo K., Nagano Y., and Togo S. Surgical outcomes of solitary colorectal metastases to the hepatic caudate lobe. Br J Surg 92 (2005) 847-848
31. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 5 (2001) 539-545
32. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
33. McMillan D.C., Wotherspoon H.A., Fearon K.C., Sturgeron C., Cooke T.G., and McArdle C.S. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170 (1995) 319-322
34. Gunter M.J., Stolzenberg-Solomon R., Cross A.J., et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66 4 (2006) 2483-2487
35. McMillan D.C., Canna K., and McArdle C.S. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90 (2003) 215-219
36. Canna K., McArdle P.A., McMillan D.C., et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92 (2005) 651-654
37. Xavier P., Belo L., Beires J., et al. Serum levels of VEGF and TNF-a and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 273 (2006) 227-231
38. Tanigawa N., Amaya N., Matsumura M., and Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15 (1997) 826-832
39. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L., et al. IL-18 regulates IL-1b-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A 97 (2000) 734-739
40. Walsh S.R., Cook E.J., Goulder F., Justin T.A., and Keeling N.J. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91 (2005) 181-184
41. Okano K., Maeba T., Modoguchi A., et al. Lymphocytic infiltration surrounding liver metastases from colorectal cancer. J Surg Oncol 82 1 (2003) 28-33
42. Wong V.K.H., Malik H.Z., Hamady Z.Z.R., et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 96 (2007) 222-225